GoodRx Holdings, Inc. Quarterly Debt-to-equity in % from Q2 2021 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: GoodRx Holdings, Inc. quarterly Debt-to-equity history and growth rate from Q2 2021 to Q3 2024.
GoodRx Holdings, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 113 %, a 20.7% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	113	+19.4	+20.7%	Sep 30, 2024
Q2 2024	112	+16.8	+17.8%	Jun 30, 2024
Q1 2024	103	+7.02	+7.29%	Mar 31, 2024
Q4 2023	96.1	-0.38	-0.39%	Dec 31, 2023
Q3 2023	93.5	-2.02	-2.11%	Sep 30, 2023
Q2 2023	94.7	+1.16	+1.24%	Jun 30, 2023
Q1 2023	96.2	+3.26	+3.51%	Mar 31, 2023
Q4 2022	96.5	+2.1	+2.23%	Dec 31, 2022
Q3 2022	95.5	-1.91	-1.96%	Sep 30, 2022
Q2 2022	93.5	-7.55	-7.47%	Jun 30, 2022
Q1 2022	93			Mar 31, 2022
Q4 2021	94.4			Dec 31, 2021
Q3 2021	97.4			Sep 30, 2021
Q2 2021	101			Jun 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.